Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/165097
Title: | De novo Mutations From Whole Exome Sequencing in Neurodevelopmental and Psychiatric Disorders: From Discovery to Application. |
Author: | Wang, Weidi Corominas Castiñeira, Roser Lin, Guan Ning |
Keywords: | Trastorns del desenvolupament Psicopatologia Developmental disabilities Pathological psychology |
Issue Date: | 3-Apr-2019 |
Publisher: | Frontiers Media |
Abstract: | Neurodevelopmental and psychiatric disorders are a highly disabling and heterogeneous group of developmental and mental disorders, resulting from complex interactions of genetic and environmental risk factors. The nature of multifactorial traits and the presence of comorbidity and polygenicity in these disorders present challenges in both disease risk identification and clinical diagnoses. The genetic component has been firmly established, but the identification of all the causative variants remains elusive. The development of next-generation sequencing, especially whole exome sequencing (WES), has greatly enriched our knowledge of the precise genetic alterations of human diseases, including brain-related disorders. In particular, the extensive usage of WES in research studies has uncovered the important contribution of de novo mutations (DNMs) to these disorders. Trio and quad familial WES are a particularly useful approach to discover DNMs. Here, we review the major WES studies in neurodevelopmental and psychiatric disorders and summarize how genes hit by discovered DNMs are shared among different disorders. Next, we discuss different integrative approaches utilized to interrogate DNMs and to identify biological pathways that may disrupt brain development and shed light on our understanding of the genetic architecture underlying these disorders. Lastly, we discuss the current state of the transition from WES research to its routine clinical application. This review will assist researchers and clinicians in the interpretation of variants obtained from WES studies, and highlights the need to develop consensus analytical protocols and validated lists of genes appropriate for clinical laboratory analysis, in order to reach the growing demands. |
Note: | Reproducció del document publicat a: https://doi.org/10.3389/fgene.2019.00258 |
It is part of: | Frontiers In Genetics, 2019, vol. 10, p. 258 |
URI: | http://hdl.handle.net/2445/165097 |
Related resource: | https://doi.org/10.3389/fgene.2019.00258 |
ISSN: | 1664-8021 |
Appears in Collections: | Articles publicats en revistes (Genètica, Microbiologia i Estadística) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
698236.pdf | 2.92 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License